NVSEF — Stock activity · TradeandTellNVSE
NVSEF
$157.90+$6.48 (+4.28%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$118.02 – $171.29
75% from low
Held by traders on TradeandTell
No one on the platform currently holds NVSEF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NVSEF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 6.65% ($10.50/share)
| Ex-date | Per share | Pay date |
|---|
| 2026-03-11 | $3.7000 | 2026-03-12 |
| 2025-03-12 | $3.5000 | 2025-03-13 |
| 2024-03-07 | $3.3000 | 2024-03-11 |
Recent trades on TradeandTell
No one on the platform has traded NVSEF yet.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $57.0B | +2.8% | $8.79 | $8.47–$9.36 | 18.0× | 1 |
| 2027 | $60.8B | +6.7% | $9.84 | $9.49–$10.49 | 16.0× | 1 |
| 2028 | $64.9B | +6.8% | $10.90 | $10.52–$11.62 | 14.5× | 1 |
| 2029 | $68.2B | +5.0% | $11.84 | $11.42–$12.62 | 13.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-07-21 | $2.17 | $2.41 | +11.1% |
| 2026-04-28 | $2.10 | $1.99 | -5.2% |
| 2026-02-04 | $1.99 | $2.03 | +2.0% |
| 2025-10-28 | $2.27 | $2.25 | -0.9% |
| 2025-07-17 | $2.35 | $2.42 | +3.0% |
| 2025-04-29 | $2.11 | $2.28 | +8.1% |
| 2025-01-31 | $1.80 | $1.98 | +10.0% |
| 2024-10-29 | $1.94 |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| NVSEFNovartis AG | $157.90 | +0.00% | $300.1B | — |
| AZNCFAstraZeneca PLC | $189.90 | -1.35% | $294.4B | — |
| CHGCFChugai Pharmaceutical Co., Ltd. | $43.22 | -0.84% | $71.1B | — |
| FSNUYFresenius SE & Co. KGaA | $13.70 | -0.95% | $123.5B | — |
| GLAXFGSK plc | $25.42 | +0.91% |
| NONOFNovo Nordisk A/S | $44.95 | -1.85% | $199.6B | — |
| RHHBFRoche Holding AG | $443.68 | -2.68% | $353.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
- Form 4 filed Jul 16, 2020↗
- Form 4 filed Jul 2, 2020↗
- Form 4 filed Jun 22, 2020↗
- Form 4 filed Jun 17, 2020↗
- Form 4 filed Jun 12, 2020↗
- Form 4 filed Jun 9, 2020↗
- Form 4 filed Jun 4, 2020↗
- Form 4 filed Nov 12, 2019↗
- Form 4 filed May 30, 2019↗
- Form 4 filed Apr 29, 2019↗
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.